Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study

Figure 1

Cohort selection: RTX = rituximab, NMO = neuromyelitis optica, and NMOSD = neuromyelitis optica spectrum disorder.